NNVC
NNVC
AMEX · Biotechnology

Nanoviricides Inc

$0.91
-0.05 (-5.59%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,353.9% upside
Low Target $21.60
Average Target $31.32
High Target $37.71
Current Price $0.91
Current
$0.91
Target
$31.32
$21.60 $31.32 avg $37.71
Scenario Analysis
Bear Case
$21.60
2,282.0%
Low target
Base Case
$31.32
+3,353.9%
Avg target
Bull Case
$37.71
+4,058.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.23
-59.3% from high
52-Week Low
$0.85
+6.7% from low
Target vs 52W High
$31.32
+1,304.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%